Amedisys, Inc.
AMED
$91.91
$0.330.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.77% | -0.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.77% | -0.59% | |||
| Cost of Revenue | 2.09% | 3.25% | |||
| Gross Profit | 1.33% | -5.35% | |||
| SG&A Expenses | 2.20% | 1.32% | |||
| Depreciation & Amortization | -4.36% | 8.85% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.07% | 2.58% | |||
| Operating Income | -1.77% | -26.70% | |||
| Income Before Tax | -166.33% | -41.12% | |||
| Income Tax Expenses | -49.56% | -25.12% | |||
| Earnings from Continuing Operations | -254.53% | -49.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 1,194.21% | 245.96% | |||
| Net Income | -220.52% | -47.65% | |||
| EBIT | -1.77% | -26.70% | |||
| EBITDA | -1.78% | -23.61% | |||
| EPS Basic | -220.51% | -47.71% | |||
| Normalized Basic EPS | 18.32% | -23.82% | |||
| EPS Diluted | -222.33% | -47.96% | |||
| Normalized Diluted EPS | 19.73% | -23.93% | |||
| Average Basic Shares Outstanding | 0.02% | 0.12% | |||
| Average Diluted Shares Outstanding | -1.16% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||